Using simulation modeling to inform intervention and implementation selection in a rapid stakeholder-engaged hybrid effectiveness-implementation randomized trial

被引:0
|
作者
Becker, Jessica E. [1 ]
Shebl, Fatma M. [2 ,3 ]
Losina, Elena [3 ,4 ]
Wilson, Anna [5 ]
Levison, Julie H. [3 ,5 ,6 ]
Donelan, Karen [5 ,7 ]
Fung, Vicki [3 ,5 ]
Trieu, Hao [5 ]
Panella, Christopher [2 ]
Qian, Yiqi [2 ]
Kazemian, Pooyan [8 ]
Bird, Bruce [9 ]
Skotko, Brian G. [3 ,10 ]
Bartels, Stephen [3 ,5 ,6 ]
Freedberg, Kenneth A. [2 ,3 ,11 ,12 ]
机构
[1] NYU, Dept Child & Adolescent Psychiat, NYU Langone Hlth, Grossman Sch Med, One Pk Ave,Seventh Floor, New York, NY 10016 USA
[2] Massachusetts Gen Hosp, Med Practice Evaluat Ctr, Boston, MA USA
[3] Harvard Med Sch, Boston, MA USA
[4] Brigham & Womens Hosp, Dept Orthoped Surg, Boston, MA USA
[5] Massachusetts Gen Hosp, Mongan Inst, Boston, MA USA
[6] Massachusetts Gen Hosp, Dept Med, Boston, MA USA
[7] Brandeis Univ, Heller Sch Social Policy & Management, Waltham, MA USA
[8] Case Western Reserve Univ, Weatherhead Sch Management, Dept Operat, Cleveland, OH USA
[9] Kennedy Krieger Inst, Dept Behav Psychol, Baltimore, MD USA
[10] Massachusetts Gen Hosp, Dept Pediat, Down Syndrome Program, Div Med Genet & Metab, Boston, MA USA
[11] Massachusetts Gen Hosp, Dept Med, Div Infect Dis, Boston, MA USA
[12] Massachusetts Gen Hosp, Dept Med, Div Gen Internal Med, Boston, MA USA
来源
基金
美国医疗保健研究与质量局;
关键词
COST-EFFECTIVENESS; MEDICAL CONDITIONS; HEALTH; COVID-19; MORTALITY; SCIENCE; DESIGNS; IMPACT;
D O I
10.1186/s43058-024-00593-w
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background Implementation research generally assumes established evidence-based practices and prior piloting of implementation strategies, which may not be feasible during a public health emergency. We describe the use of a simulation model of the effectiveness of COVID-19 mitigation strategies to inform a stakeholder-engaged process of rapidly designing a tailored intervention and implementation strategy for individuals with serious mental illness (SMI) and intellectual/developmental disabilities (ID/DD) in group homes in a hybrid effectiveness-implementation randomized trial.Methods We used a validated dynamic microsimulation model of COVID-19 transmission and disease in late 2020/early 2021 to determine the most effective strategies to mitigate infections among Massachusetts group home staff and residents. Model inputs were informed by data from stakeholders, public records, and published literature. We assessed different prevention strategies, iterated over time with input from multidisciplinary stakeholders and pandemic evolution, including varying symptom screening, testing frequency, isolation, contact-time, use of personal protective equipment, and vaccination. Model outcomes included new infections in group home residents, new infections in group home staff, and resident hospital days. Sensitivity analyses were performed to account for parameter uncertainty. Results of the simulations informed a stakeholder-engaged process to select components of a tailored best practice intervention and implementation strategy.Results The largest projected decrease in infections was with initial vaccination, with minimal benefit for additional routine testing. The initial level of actual vaccination in the group homes was estimated to reduce resident infections by 72.4% and staff infections by 55.9% over the 90-day time horizon. Increasing resident and staff vaccination uptake to a target goal of 90% further decreased resident infections by 45.2% and staff infections by 51.3%. Subsequent simulated removal of masking led to a 6.5% increase in infections among residents and 3.2% among staff. The simulation model results were presented to multidisciplinary stakeholders and policymakers to inform the "Tailored Best Practice" package for the hybrid effectiveness-implementation trial.Conclusions Vaccination and decreasing vaccine hesitancy among staff were predicted to have the greatest impact in mitigating COVID-19 risk in vulnerable populations of group home residents and staff. Simulation modeling was effective in rapidly informing the selection of the prevention and implementation strategy in a hybrid effectiveness-implementation trial. Future implementation may benefit from this approach when rapid deployment is necessary in the absence of data on tailored interventions.Trial registration ClinicalTrials.gov NCT04726371
引用
收藏
页数:13
相关论文
共 50 条
  • [31] A Digital Intervention to Improve Skin Self-Examination Among Survivors of Melanoma: Protocol for a Type-1 Hybrid Effectiveness-Implementation Randomized Trial
    Manne, Sharon
    Heckman, Carolyn J.
    Frederick, Sara
    Schaefer, Alexis A.
    Studts, Christina R.
    Khavjou, Olga
    Honeycutt, Amanda
    Berger, Adam
    Liu, Hao
    [J]. JMIR RESEARCH PROTOCOLS, 2024, 13
  • [32] Testing health information technology tools to facilitate health insurance support: a protocol for an effectiveness-implementation hybrid randomized trial
    DeVoe, Jennifer E.
    Huguet, Nathalie
    Likumahuwa-Ackman, Sonja
    Angier, Heather
    Nelson, Christine
    Marino, Miguel
    Cohen, Deborah
    Sumic, Aleksandra
    Hoopes, Megan
    Harding, Rose L.
    Dearing, Marla
    Gold, Rachel
    [J]. IMPLEMENTATION SCIENCE, 2015, 10
  • [33] An effectiveness-implementation hybrid trial study protocol targeting posttraumatic stress disorder and comorbidity
    Zatzick, Douglas F.
    Russo, Joan
    Darnell, Doyanne
    Chambers, David A.
    Palinkas, Lawrence
    Van Eaton, Erik
    Wang, Jin
    Ingraham, Leah M.
    Guiney, Roxanne
    Heagerty, Patrick
    Comstock, Bryan
    Whiteside, Lauren K.
    Jurkovich, Gregory
    [J]. IMPLEMENTATION SCIENCE, 2016, 11
  • [34] An effectiveness-implementation hybrid trial for informatics-based cancer symptom management.
    Smith, Justin D.
    Garcia, Sofia F.
    Penedo, Frank J.
    Scholtens, Denise M.
    Yanez, Betina
    Kircher, Sheetal Mehta
    Cella, David
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (29)
  • [35] ACCELERATING EHEALTH BEHAVIORAL INTERVENTIONS INTO PRACTICE: THE KEEP IT UP! HYBRID EFFECTIVENESS-IMPLEMENTATION TRIAL
    Mustanski, Brian
    Benbow, Nanette
    Macapagal, Kathryn
    Brown, C. Hendricks
    Smith, Justin
    Shackman, Bruce R.
    Linas, Benjamin P.
    Janulis, Patrick
    [J]. ANNALS OF BEHAVIORAL MEDICINE, 2020, 54 : S480 - S480
  • [36] A randomized controlled trial of customized adherence enhancement (CAE-E): study protocol for a hybrid effectiveness-implementation project
    Levin, Jennifer B.
    Briggs, Farren
    Blixen, Carol
    Bauer, Mark
    Einstadter, Douglas
    Albert, Jeffrey M.
    Weise, Celeste
    Woods, Nicole
    Fuentes-Casiano, Edna
    Cassidy, Kristin A.
    Rentsch, Julie
    Sarna, Kaylee
    Sajatovic, Martha
    [J]. TRIALS, 2022, 23 (01)
  • [37] The implementation and sustainment facilitation strategy improved implementation effectiveness and intervention effectiveness: Results from a cluster-randomized, type 2 hybrid trial
    Garner, Bryan R.
    Gotham, Heather J.
    Chaple, Michael
    Martino, Steve
    Ford II, James H.
    Roosa, Mathew R.
    Speck, Kathryn J.
    Vandersloot, Denna
    Bradshaw, Michael
    Ball, Elizabeth L.
    Toro, Alyssa K.
    Griggs, Christopher
    Tueller, Stephen J.
    [J]. IMPLEMENTATION RESEARCH AND PRACTICE, 2020, 1
  • [38] COSMOS—improving the quality of life in nursing home patients: protocol for an effectiveness-implementation cluster randomized clinical hybrid trial
    Bettina S. Husebo
    Elisabeth Flo
    Dag Aarsland
    Geir Selbaek
    Ingelin Testad
    Christine Gulla
    Irene Aasmul
    Clive Ballard
    [J]. Implementation Science, 10
  • [39] TIME – Targeted interdisciplinary model for evaluation and treatment of neuropsychiatric symptoms: protocol for an effectiveness-implementation cluster randomized hybrid trial
    Bjørn Lichtwarck
    Geir Selbaek
    Øyvind Kirkevold
    Anne Marie Mork Rokstad
    Jūratė Šaltytė Benth
    Janne Myhre
    Solvor Nybakken
    Sverre Bergh
    [J]. BMC Psychiatry, 16
  • [40] Testing health information technology tools to facilitate health insurance support: a protocol for an effectiveness-implementation hybrid randomized trial
    Jennifer E. DeVoe
    Nathalie Huguet
    Sonja Likumahuwa-Ackman
    Heather Angier
    Christine Nelson
    Miguel Marino
    Deborah Cohen
    Aleksandra Sumic
    Megan Hoopes
    Rose L. Harding
    Marla Dearing
    Rachel Gold
    [J]. Implementation Science, 10